Stoneridge Investment Partners LLC Durect Corp Transaction History

Stoneridge Investment Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 05, 2020	BUY	$1.33 - $2.76 $3,626 - $7,526	2,727 Added 18.19%	17,719 $41,000
Q2 2019 Jul 29, 2019	BUY	$0.51 - $0.86 $7,645 - $12,893	14,992 New	14,992 $10,000
Q2 2018 Jul 31, 2018	SELL	$1.56 - $2.51 $22,562 - $36,302	-14,463 Closed	0 $0
Q1 2018 Apr 27, 2018	SELL	$0.91 - $2.24 $34,110 - $83,964	-37,484 Reduced 72.16%	14,463 $31,000
Q4 2017 Feb 05, 2018	BUY	$0.78 - $2.1 $11,700 - $31,500	15,000 Added 40.6%	51,947 $48,000
Q3 2017 Nov 02, 2017	BUY	$1.55 - $1.82 $57,267 - $67,243	36,947	36,947 $65,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $175M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Stoneridge Investment Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Stoneridge Investment Partners LLC with notifications on news.